Furthermore, they found that both macrophages and dendritic cells in ACPA-negative RA had significantly upregulated gene expressions of chemokine ligand 13 (CCL13), matrix metalloproteinase-3 (MMP3), and chemokine ligand 18 (CCL18). This evidence concerns the gene PRTN3 and rheumatoid arthritis.